title: Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
authors.forename: Christelle
authors.initials: C
authors.lastname: Kassis
authors.forename: Richard E
authors.initials: RE
authors.lastname: Champlin
authors.forename: Ray Y
authors.initials: RY
authors.lastname: Hachem
authors.forename: Chitra
authors.initials: C
authors.lastname: Hosing
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Tarrand
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Perego
authors.forename: Joyce L
authors.initials: JL
authors.lastname: Neumann
authors.forename: Issam I
authors.initials: II
authors.lastname: Raad
authors.forename: Roy F
authors.initials: RF
authors.lastname: Chemaly
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D003428:Cross Infection / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D017053:Infection Control / Q000379:methods*; D008297:Male; D008875:Middle Aged; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab